Use of tamoxifen by young women is influenced by fertility concerns

[News]

The risk of breast cancer recurrence and mortality is decreased by endocrine therapy (ET) such as tamoxifen, but younger patients may decline it or discontinue treatment early if they are concerned...

More... (http://www.medicalnewstoday.com/releases/298537.php)